You have 9 free searches left this month | for more free features.

Photopic negative response

Showing 1 - 25 of >10,000

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Optical Coherence Tomography Angiography and Photopic Negative

Completed
  • Open Angle Glaucoma
  • Optical Coherence Tomography- Angiography
  • Photopic negative response
  • Banhā, Benha, Egypt
    Benha University
Oct 29, 2021

Triple Negative Breast Tumors Trial (Xiaopi granules, Xiaopi decoction, Placebo)

Not yet recruiting
  • Triple Negative Breast Neoplasms
  • Xiaopi granules
  • +2 more
  • (no location specified)
Nov 22, 2023

Checkpoint Inhibitors in Triple Negative Breast

Recruiting
  • Triple Negative Breast Cancer
  • Whole Genome Sequencing
  • +7 more
  • Barcelona, Spain
    Vall d'Hebron Institute of Oncology
Jun 20, 2023

Breast Cancer, Contrast Enhanced Ultrasound Trial in Hershey (Lumason)

Not yet recruiting
  • Breast Cancer
  • Contrast Enhanced Ultrasound
  • Hershey, Pennsylvania
    Penn State Health College of Medicine
Jul 19, 2023

Multiple Myeloma Trial (Continued treatment adapted to the response)

Completed
  • Multiple Myeloma
  • Continued treatment adapted to the response
  • (no location specified)
Jan 14, 2023

Edema, Erythema, Estrogen Receptor Negative Trial in Houston (Laboratory Biomarker Analysis, Pembrolizumab)

Active, not recruiting
  • Edema
  • +8 more
  • Laboratory Biomarker Analysis
  • Pembrolizumab
  • Houston, Texas
    M D Anderson Cancer Center
Jan 23, 2023

BRCA and NACT in TNBC Patients

Completed
  • Triple-Negative Breast Cancer
  • BRCA1/2 genetic testing
  • Rome, RM, Italy
    Fondazione Policlinico Universitario Agostino Gemelli IRCCS
Feb 20, 2023

Immune Environment in Response to Therapy in Breast Cancer

Recruiting
  • Breast Cancer
  • +3 more
  • Collection of personal health information from women treated at the University of Pennsylvania under an approved HIPAA waiver.
  • Philadelphia, Pennsylvania
    Abramson Cancer Center
Sep 15, 2022

Stress Response, Multitasking Behavior, Mental Stress Trial (100% Cranberry Juice, 100% Cranberry Juice + 200 mg L-theanine,

Not yet recruiting
  • Stress Response
  • +5 more
  • 100% Cranberry Juice
  • +2 more
  • (no location specified)
Sep 27, 2023

Epigenetic Silencing of MicroRNA for Predicting Therapeutic

Active, not recruiting
  • Head and Neck Squamous Cell Carcinoma
  • Not interventional
  • Albuquerque, New Mexico
    University of New Mexico - Cancer Center
Oct 4, 2022

Radiation OmisSion in PAtients With CLinically Node Negative

Not yet recruiting
  • Breast Cancer
    • (no location specified)
    May 10, 2023

    Anatomic Stage I Breast Cancer AJCC v8, Anatomic Stage II Breast Cancer AJCC v8, Anatomic Stage III Breast Cancer AJCC v8 Trial

    Not yet recruiting
    • Anatomic Stage I Breast Cancer AJCC v8
    • +3 more
    • Pembrolizumab
    • +5 more
    • (no location specified)
    Apr 12, 2023

    Triple-negative Breast Cancers in Order to Validate Interest of

    Not yet recruiting
    • Triple Negative Breast Cancer
    • Organoid
    • Establishment of ex vivo breast cancer organoid models
    • Caen, France
      Centre François Baclesse
    Aug 9, 2022

    Neoadjuvant Chemotherapy in HER2 Negative Breast Cancer Using

    Recruiting
    • HER2 Negative Breast Cancer
    • Response monitoring (no intervention)
    • Albuquerque, New Mexico
      University of New Mexico Comprehensive Cancer Center
    Apr 21, 2022

    Breast Cancer, Triple Negative Breast Cancer Trial in New York (Sodium (Na) Magnetic Resonance Imaging (MRI), Dynamic Contrast-

    Terminated
    • Breast Cancer
    • Triple Negative Breast Cancer
    • Sodium (Na) Magnetic Resonance Imaging (MRI)
    • Dynamic Contrast- Enhanced (DCE) MRI
    • New York, New York
      NYU Langone Health
    Aug 1, 2022

    Anatomic Stage IIB Breast Cancer AJCC v8, Anatomic Stage III Breast Cancer AJCC v8, Anatomic Stage IIIA Breast Cancer AJCC v8

    Active, not recruiting
    • Anatomic Stage IIB Breast Cancer AJCC v8
    • +19 more
    • Gilbert, Arizona
    • +4 more
    Dec 6, 2022

    Triple Negative Breast Cancer, Breast Cancer Trial in United States (Carboplatin, Docetaxel, Doxorubicin)

    Recruiting
    • Triple Negative Breast Cancer
    • Breast Cancer
    • Fairway, Kansas
    • +5 more
    Jan 26, 2023

    HER2-negative Breast Cancer, Neoadjuvant Therapy, Pathological Complete Response Trial in Beijing (Camrelizumab with vinorelbine

    Recruiting
    • HER2-negative Breast Cancer
    • +5 more
    • Camrelizumab with vinorelbine and cisplatin
    • Beijing, Beijing, China
      Peking University First Hospital
    Oct 15, 2022

    Glaucoma Trial in Seongnam (Nicotinamide(Mitovita), Placebo)

    Recruiting
    • Glaucoma
    • Nicotinamide(Mitovita)
    • Placebo
    • Seongnam, Bundang-gu, Korea, Republic of
      CHA University Bundang Medical Center
    Oct 9, 2023

    Locally Recurrent/Metastatic Triple Negative Breast Cancer Trial in United States (radiation, drug, procedure)

    Recruiting
    • Locally Recurrent/Metastatic Triple Negative Breast Cancer
    • external beam radiation therapy
    • +2 more
    • Basking Ridge, New Jersey
    • +6 more
    Aug 8, 2022

    Triple Negative Breast Cancer, Metastatic Breast Cancer Trial in Boston (Pembrolizumab, PVX-410)

    Active, not recruiting
    • Triple Negative Breast Cancer
    • Metastatic Breast Cancer
    • Boston, Massachusetts
    • +2 more
    Dec 21, 2022

    Triple Negative Breast Cancer, Chemo Effect, Simvastatin Adverse Reaction Trial in Jakarta Pusat (Simvastatin 40mg, Placebo)

    Recruiting
    • Triple Negative Breast Cancer
    • +2 more
    • Simvastatin 40mg
    • Placebo
    • Jakarta Pusat, DKI Jakarta, Indonesia
      Dr. Cipto Mangunkusumo National Central General Hospital
    Sep 22, 2022

    Triple Negative Breast Cancer, Vitamin D Deficiency, Invasive Breast Cancer Trial in Winston-Salem (drug, dietary supplement,

    Recruiting
    • Triple Negative Breast Cancer
    • +2 more
    • Standard of Care Neoadjuvant Chemotherapy
    • +2 more
    • Winston-Salem, North Carolina
      Wake Forest Baptist Health Sciences
    Feb 8, 2022

    TNBC - Triple-Negative Breast Cancer, Breast Cancer Trial (Pembrolizumab, Radiation Therapy, Axatilimab)

    Not yet recruiting
    • TNBC - Triple-Negative Breast Cancer
    • Breast Cancer
    • (no location specified)
    Aug 4, 2022

    Metastatic Breast Cancer Trial in Amsterdam (Nivolumab, Cisplatin, Low dose doxorubicin)

    Recruiting
    • Metastatic Breast Cancer
    • Amsterdam, Netherlands
      Antoni van Leeuwenhoek
    Mar 21, 2022